Urologic Health Secures $11

NewLimit

NewLimit is a biotechnology company working to radically extend human healthspan. We’re developing medicines to treat age-related diseases by reprogramming the epigenome, a new therapeutic mechanism to restore regenerative potential in aged and diseased cells. We leverage functional genomics, pooled perturbation screening, and machine learning models to unravel the biology of epigenetic aging and disease using experiments of unprecedented scale. All correspondence from NewLimit will come from an @NewLimit.com email address.

Alitheon

Alitheon provides the last solution you will need for identification, authentication, and traceability of parts and products with our fail-proof, simple-to-use FeaturePrint system. FeaturePrint is an advanced machine-vision technology that provides for items, what fingerprints are for people – a unique and persistent identifier for the one in millions. FeaturePrint serializes items. As such, it enables track & trace, eliminates counterfeits and gray markets, and reduces human error ....all with just a photo using a standard camera. No bar codes, No QR codes, No stickers, No tags, No 'invisible' dust, No markers, No holograms, No special cameras, No special lighting, No Nonsense!

The Ryl Company™

The Ryl Company™ is The Modern Tea Company — where nostalgic taste, clean ingredients, and functional benefits come together. Our flagship brand, Ryl Tea, reimagines the classic tea experience with zero sugar, 5 calories or less, nothing artificial, and antioxidant-powered functionality. We believe better-for-you should taste like the flavors you grew up loving. That’s why we exist: to help people Rethink Your Liquids (RYL). Available nationwide.

Tavo Biotherapeutics

Tavo Biotherapeutics is developing innovative treatments to address critical unmet needs in ophthalmology. TAV-001 engages two novel targets that represent fundamental mechanisms underlying the pathology of glaucoma-related neurodegeneration. In pre-clinical studies, TAV-001 has shown signals of neuroprotection as well as substantial reduction in intraocular pressure, suggesting that it could represent the first disease-modifying pharmaceutical therapy for these patients. TAV-001 is expected to enter a Phase 1 clinical trial in glaucoma patients in 2025. TAV-002 represents a potential first-in-class treatment for retinal disease, including diabetic retinopathy, diabetic macular edema, and both wet and dry age-related macular degeneration. Tavo has initiated IND-enabling activities for this program.

Adaptive Innovations Corp

Adaptive Innovations is an engineering firm and system integrator specializing in the design, fabrication, integration, and installation of custom equipment, automation & robotic solutions, tooling, fixtures, and gages. Comprised of a diverse group of professional engineers with backgrounds in design, controls, manufacturing, and electrical engineering disciplines, our outstanding team can help position your company to compete in today’s global economy. Combining industry best designs with exceptional process knowledge, fed by cross-industry exposure, Adaptive sets itself apart from its competition through every step of a project. We have a history of consistently delivering cost effective solutions, an excellent on-time delivery record, and unparalleled customer service, making Adaptive the engineering partner you can count on. Adaptive is considered the market leader in the design and fabrication of environmental test fixtures for testing such as HALT/HASS, ESS, and ED vibration or combined environments. We have experience with a wide array of automated solutions, including, assembly, pick-n-place, adhesive dispense, soldering, sorting, inspection etc. We're a Fanuc approved integrator, and have also integrated robots from ABB, Epson, Denso, and Adept. Our controls engineers are familiar with Beckhoff, Allen Bradley, Fanuc, Siemens, Mitsubishi, and National Instruments, contrllers and have a wide range of experience with robotic applications.